Expert Analysis: Deprescribing, Sarcopenia and Safer Geriatric Trials
Five expert insights on deprescribing, sarcopenia treatments, geriatric oncology, and building safer trials for frail older adults—plus survey findings and trainee pathways to advance care and research.
Robert Maxwell
Sep 30, 2025
deprescribing studies
sarcopenia trials
geriatric oncology
frailty interventions
